GC Cell Corporation (KOSDAQ:144510)
South Korea · Delayed Price · Currency is KRW 10,090
-10 (-0.10%)
Nov 2, 2026, 3:30 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 151.62 billion as of October 30, 2026. It is the 24,234th most valuable company in the world and the 982nd biggest in South Korea. Its market cap has decreased by 56.03% in one year.
Market Cap
151.62B
Enterprise Value
262.27B
Revenue
162.00B
Global Rank
Country Rank
#982 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 151.62B, a decrease of -70.13%. That is a compound annual growth rate of -11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 151.62B | -59.40% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 244.71B |
| HLB Therapeutics | 219.91B |
| GC Genome | 215.22B |
| Bioneer | 175.77B |
| Helixmith | 170.37B |
| NeoImmuneTech | 155.82B |
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |